Daily Health
·15/04/2026
A remarkable medical breakthrough has occurred in Norway, where a 63-year-old man has seemingly been cured of HIV thanks to a stem cell transplant from his brother. This groundbreaking case offers renewed hope in the ongoing fight against the virus.
The patient, diagnosed with HIV in 2006, also suffered from myelodysplastic syndrome, a life-threatening blood cancer. In 2018, doctors opted for a stem cell transplant to treat the cancer. Unbeknownst to the medical team initially, his brother, who was a compatible bone marrow donor, carried a rare CCR5-delta 32 mutation. This genetic anomaly makes immune cells naturally resistant to HIV-1 infection.
While the primary goal of the transplant was to combat the patient's cancer by replacing his diseased bone marrow with healthy stem cells, the presence of the CCR5-delta 32 mutation in the donor cells provided an unexpected benefit. This mutation prevents the virus from entering certain white blood cells, effectively blocking its replication.
Four years post-transplant, and two years after discontinuing antiretroviral therapy, the patient shows no detectable signs of HIV in his system. Doctors are confident in declaring him cured. The odds of such an outcome were astronomically low, involving not only the rarity of the genetic mutation (present in only about 1% of the population with two copies) but also the compatibility between siblings, which occurs only about 25% of the time. The patient himself described the event as "like winning the lottery twice."
While stem cell transplantation is a high-risk procedure and not a scalable solution for the millions living with HIV, this case provides invaluable data for researchers. It reinforces the potential of targeting the CCR5 receptor for HIV eradication and offers a beacon of hope, demonstrating that a cure is indeed possible, even in complex medical scenarios.









